Numinus Wellness Future Growth
Future criteria checks 5/6
Numinus Wellness is forecast to grow earnings and revenue by 60.3% and 25.8% per annum respectively while EPS is expected to grow by 63.9% per annum.
Key information
60.3%
Earnings growth rate
63.9%
EPS growth rate
| Pharmaceuticals earnings growth | 21.5% |
| Revenue growth rate | 25.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Jul 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 8/31/2027 | 50 | 8 | N/A | N/A | 1 |
| 8/31/2026 | 34 | -3 | N/A | N/A | 1 |
| 8/31/2025 | 24 | -8 | N/A | N/A | 1 |
| 8/31/2024 | 20 | -17 | N/A | N/A | 1 |
| 5/31/2024 | 22 | -26 | -15 | -15 | N/A |
| 2/29/2024 | 23 | -27 | -17 | -17 | N/A |
| 11/30/2023 | 23 | -28 | -19 | -19 | N/A |
| 8/31/2023 | 23 | -30 | -23 | -23 | N/A |
| 5/31/2023 | 19 | -44 | -29 | -29 | N/A |
| 2/28/2023 | 14 | -45 | -30 | -29 | N/A |
| 11/30/2022 | 11 | -46 | -30 | -28 | N/A |
| 8/31/2022 | 6 | -45 | -27 | -26 | N/A |
| 5/31/2022 | 3 | -28 | -22 | -21 | N/A |
| 2/28/2022 | 3 | -26 | -21 | -20 | N/A |
| 11/30/2021 | 2 | -22 | -20 | -19 | N/A |
| 8/31/2021 | 2 | -19 | -16 | -16 | N/A |
| 5/31/2021 | 1 | -14 | -14 | -13 | N/A |
| 2/28/2021 | 1 | -13 | -11 | -11 | N/A |
| 11/30/2020 | 1 | -11 | -7 | -7 | N/A |
| 8/31/2020 | 1 | -10 | -5 | -5 | N/A |
| 5/31/2020 | 1 | -10 | -3 | -3 | N/A |
| 2/29/2020 | 0 | -8 | -2 | -2 | N/A |
| 11/30/2019 | 0 | -7 | -4 | -3 | N/A |
| 8/31/2019 | 0 | -7 | -5 | -4 | N/A |
| 8/31/2018 | 3 | -3 | -3 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LR23 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: LR23 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: LR23 is expected to become profitable in the next 3 years.
Revenue vs Market: LR23's revenue (25.8% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: LR23's revenue (25.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LR23's Return on Equity is forecast to be high in 3 years time